Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Dechant

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Effector mechanisms of recombinant IgA antibodies against epidermal growth factor receptorMichael Dechant, Thomas Beyer, Tanja Schneider-Merck, et al.
American Journal of Nephrology|October 26, 2013
Antibody-dependent cellular cytotoxicity in patients on chronic hemodialysisTill Koch, Stefanie Derer, Matthias Staudinger, et al.
Blood|October 24, 2002
Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killingMichael Dechant, Gestur Vidarsson, Bernhard Stockmeyer, et al.
Cancer Science|March 25, 2010
Fc-engineered EGF-R antibodies mediate improved antibody-dependent cellular cytotoxicity (ADCC) against KRAS-mutated tumor cellsMartin Schlaeth, Sven Berger, Stefanie Derer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 2010
A recombinant bispecific single-chain fragment variable specific for HLA class II and Fc alpha RI (CD89) recruits polymorphonuclear neutrophils for efficient lysis of malignant B lymphoid cellsYvonne Guettinger, Karin Barbin, Matthias Peipp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2011
Recombinant dimeric IgA antibodies against the epidermal growth factor receptor mediate effective tumor cell killingStefan Lohse, Stefanie Derer, Thomas Beyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptorsMarielle A Otten, Esther Rudolph, Michael Dechant, et al.
Mabs|February 5, 2014
Effect of a tail piece cysteine deletion on biochemical and functional properties of an epidermal growth factor receptor-directed IgA2m(1) antibodyChristina Brunke, Stefan Lohse, Stefanie Derer, et al.
The Journal of Biological Chemistry|June 9, 2012
Characterization of a mutated IgA2 antibody of the m(1) allotype against the epidermal growth factor receptor for the recruitment of monocytes and macrophagesStefan Lohse, Christina Brunke, Stefanie Derer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2008
Tumor cell killing mechanisms of epidermal growth factor receptor (EGFR) antibodies are not affected by lung cancer-associated EGFR kinase mutationsMatthias Peipp, Tanja Schneider-Merck, Michael Dechant, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Effector mechanisms of recombinant IgA antibodies against epidermal growth factor receptorMichael Dechant, Thomas Beyer, Tanja Schneider-Merck, et al.
American Journal of Nephrology|October 26, 2013
Antibody-dependent cellular cytotoxicity in patients on chronic hemodialysisTill Koch, Stefanie Derer, Matthias Staudinger, et al.
Blood|October 24, 2002
Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killingMichael Dechant, Gestur Vidarsson, Bernhard Stockmeyer, et al.
Cancer Science|March 25, 2010
Fc-engineered EGF-R antibodies mediate improved antibody-dependent cellular cytotoxicity (ADCC) against KRAS-mutated tumor cellsMartin Schlaeth, Sven Berger, Stefanie Derer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 2010
A recombinant bispecific single-chain fragment variable specific for HLA class II and Fc alpha RI (CD89) recruits polymorphonuclear neutrophils for efficient lysis of malignant B lymphoid cellsYvonne Guettinger, Karin Barbin, Matthias Peipp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2011
Recombinant dimeric IgA antibodies against the epidermal growth factor receptor mediate effective tumor cell killingStefan Lohse, Stefanie Derer, Thomas Beyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptorsMarielle A Otten, Esther Rudolph, Michael Dechant, et al.
Mabs|February 5, 2014
Effect of a tail piece cysteine deletion on biochemical and functional properties of an epidermal growth factor receptor-directed IgA2m(1) antibodyChristina Brunke, Stefan Lohse, Stefanie Derer, et al.
The Journal of Biological Chemistry|June 9, 2012
Characterization of a mutated IgA2 antibody of the m(1) allotype against the epidermal growth factor receptor for the recruitment of monocytes and macrophagesStefan Lohse, Christina Brunke, Stefanie Derer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2008
Tumor cell killing mechanisms of epidermal growth factor receptor (EGFR) antibodies are not affected by lung cancer-associated EGFR kinase mutationsMatthias Peipp, Tanja Schneider-Merck, Michael Dechant, et al.
Pageof 3